OBJECTIVE: To study changes in cerebrospinal fluid (CSF) protein markers of blood-CSF barrier integrity and immunological reactions during surgical stress. SUBJECTS AND METHODS: Thirty-five patients without neurological or psychiatric disorders undergoing knee replacements had CSF and serum samples drawn from spinal and arterial catheters before, 3 h after and the morning after surgery. RESULTS: Serum albumin decreased during surgery and CSF albumin decreased during and after surgery, and, as a consequence, the CSF/serum albumin ratio decreased significantly during the study period, especially after the intervention. In contrast, CSF concentrations of beta-2-microglobuline (beta2M) increased significantly during surgery and remained high. The CSF general marker beta-trace protein (betaTP) remained unchanged. CONCLUSIONS: Central nervous system protein reactions to a non-neurological surgical intervention include sharply decreased permeability of albumin into the CSF and signs of intrathecal inflammatory activity.
OBJECTIVE: To study changes in cerebrospinal fluid (CSF) protein markers of blood-CSF barrier integrity and immunological reactions during surgical stress. SUBJECTS AND METHODS: Thirty-five patients without neurological or psychiatric disorders undergoing knee replacements had CSF and serum samples drawn from spinal and arterial catheters before, 3 h after and the morning after surgery. RESULTS: Serum albumin decreased during surgery and CSF albumin decreased during and after surgery, and, as a consequence, the CSF/serum albumin ratio decreased significantly during the study period, especially after the intervention. In contrast, CSF concentrations of beta-2-microglobuline (beta2M) increased significantly during surgery and remained high. The CSF general marker beta-trace protein (betaTP) remained unchanged. CONCLUSIONS: Central nervous system protein reactions to a non-neurological surgical intervention include sharply decreased permeability of albumin into the CSF and signs of intrathecal inflammatory activity.
Authors: Johannes Brettschneider; Helga Mogel; Vera Lehmensiek; Tino Ahlert; Sigurd Süssmuth; Albert C Ludolph; Hayrettin Tumani Journal: Neurochem Res Date: 2008-05-15 Impact factor: 3.996
Authors: Sara Bromander; Rolf Anckarsäter; Bo Ahrén; Marianne Kristiansson; Kaj Blennow; Agneta Holmäng; Henrik Zetterberg; Henrik Anckarsäter; Caroline E Wass Journal: J Neural Transm (Vienna) Date: 2010-08-10 Impact factor: 3.575
Authors: Niklas Mattsson; Daniel Bremell; Rolf Anckarsäter; Kaj Blennow; Henrik Anckarsäter; Henrik Zetterberg; Lars Hagberg Journal: BMC Neurol Date: 2010-06-22 Impact factor: 2.474
Authors: Maria Bjerke; Erik Portelius; Lennart Minthon; Anders Wallin; Henrik Anckarsäter; Rolf Anckarsäter; Niels Andreasen; Henrik Zetterberg; Ulf Andreasson; Kaj Blennow Journal: Int J Alzheimers Dis Date: 2010-07-15
Authors: Erik Portelius; Mikko Hölttä; Hilkka Soininen; Maria Bjerke; Henrik Zetterberg; Anni Westerlund; Sanna-Kaisa Herukka; Kaj Blennow; Niklas Mattsson Journal: Neuromolecular Med Date: 2014-04-18 Impact factor: 3.843
Authors: Sara Bromander; Rolf Anckarsäter; Marianne Kristiansson; Kaj Blennow; Henrik Zetterberg; Henrik Anckarsäter; Caroline E Wass Journal: J Neuroinflammation Date: 2012-10-24 Impact factor: 8.322
Authors: Jan Hirsch; Susana Vacas; Niccolo Terrando; Miao Yuan; Laura P Sands; Joel Kramer; Kevin Bozic; Mervyn M Maze; Jacqueline M Leung Journal: J Neuroinflammation Date: 2016-08-30 Impact factor: 8.322